Subsidies are now a deal condition: what JD.com's Ceconomy clearance teaches buyers

Cross-border buyers in Europe used to plan around two regulatory questions: does the deal harm competition, and does it touch national security. On 3 November the European Commission showed how much weight a third question now carries. It approved JD.com's acquisition of CECONOMY, the parent of MediaMarkt, Saturn and MediaWorld, under the Foreign Subsidies Regulation, but only after an in-depth investigation and on condition that the parties honour commitments for ten years. For any buyer whose balance sheet includes money from a government outside the EU, that review is now part of the price, the timetable and the documents.

What the Commission decided

The facts come from the Commission's own release. It found that JD.com had received subsidies from China "in the form of preferential financing, tax incentives and grants" that were liable to distort the internal market. Its concern was not only the money. The Commission found that those subsidies had helped build the logistics and technology capabilities JD.com would bring to CECONOMY, and that they could improve the combined group's capacity to finance its European business and price aggressively against rivals.

The remedy is behavioural, not a sale of assets. Dealings between JD.com and CECONOMY, including any financing JD.com provides, must be on market terms. JD.com must offer its warehousing, logistics and technology services to third-party retailers on the same terms as it offers them to CECONOMY. After a market test, the parties strengthened the financing commitments and improved the terms for third parties. An independent trustee will monitor compliance under the Commission's supervision.

CECONOMY said the decision was the last outstanding regulatory condition in the offer document, after foreign direct investment approvals in Germany, France, Italy, Spain and Austria, and that closing was expected within days.

The timetable is the first cost

JD.com announced its offer of €4.60 a share in July 2025, valuing CECONOMY at about €2.2 billion, and expected to complete it in the first half of 2026. The in-depth probe opened in May, according to PYMNTS. Clearance came in November. The deal survived, but it is closing several months later than planned, after three regulatory tracks: merger control, investment screening in five countries, and foreign subsidies.

The question is no longer only whether a buyer can pay, but what the money behind it obliges the deal to promise.

The regulation applies widely. Under the FSR, a deal must be notified when the target, a merging party or a joint venture is established in the EU with EU turnover of at least €500 million, and the parties received at least €50 million in combined foreign financial contributions from non-EU countries in the three years before the deal. The concept is broader than grants: in this case the Commission pointed to preferential financing and tax incentives as well, which is why the rule matters well beyond Chinese buyers. Sovereign-backed investors, state-owned groups and companies with state financing in their past can all meet the threshold.

At the end of an in-depth review, the Commission has three options: accept commitments, prohibit the deal, or issue a no-objection decision.

What it means across the table

For sellers, a bid from a buyer with state money behind it should be weighed on certainty and time, not only price. A higher headline offer that brings a foreign-subsidies review, investment screening and possible commitments may be worth less than a lower offer that closes in a quarter. Long-stop dates, ticking fees and reverse break fees are where that difference is priced.

For buyers, the work starts before signing. Mapping every foreign financial contribution across the group for the past three years is a data exercise, and it takes time. The CECONOMY case also shows that the Commission looks at what the buyer brings to the target, such as logistics, technology or cheap intra-group financing, not just at the cash paid for the shares.

For both sides, remedy risk needs an owner. Who must accept commitments, how far they can go, and what happens if they reach the target's day-to-day trading are questions for the purchase agreement, not for after the review opens. Ten years of market-terms obligations on intra-group financing, for example, will shape how a new owner can fund the business it just bought.

For competitors, the market test matters. The Commission said it relied on feedback from the parties' rivals, and the commitments were strengthened as a result.

Questions to ask

Does the buyer, or any shareholder behind it, meet the FSR thresholds, and has anyone mapped the contributions?
Is the long-stop date realistic for merger control, investment screening and a foreign-subsidies review running in parallel?
How far is the buyer obliged to go in offering commitments, and who bears the cost of a delay?
Would any likely commitment, such as market-terms financing, change the business plan after closing?
Which competitors are likely to respond to a market test, and what will they ask for?

What the Commission decided

The timetable is the first cost

What it means across the table

Questions to ask

Sources